Serial 90338968
Live / Applied — Suspended — suspension check completed, case still suspended (as of 20 May 2025)
What this means for you
Not registered yet, but its 24 Nov 2020 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90338968
- Mark type
- Design / logo
- Filed
- 24 Nov 2020
- Published for opposition
- 18 Jan 2022
- Attorney of record
- Adriano Pacifici
Goods and services
- Class 005 — Pharmaceuticals: Analgesic balm; Analgesic preparations; Balms for medical purposes; Medicinal oils; Motion sickness medicines; Motion sickness treatment preparations; Nausea treatment preparations; Medicated balms for treatment of motion sickness; Medicinal herbal preparations
- Class 010 — Medical apparatus: Personal protective equipment (PPE), namely, face shields for use in the medical and dental fields; Sanitary masks for medical wellness purposes; Sanitary masks for protection against viral infection; Surgical masks
Owner
- HONG KONG ZIHUA PHARMACEUTICAL LIMITED, KOWLOON, HK
- HONG KONG ZIHUA PHARMACEUTICAL LIMITED, KOWLOON, HK
Prosecution history
- 22 Nov 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 21 Nov 2025 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
- 20 May 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 15 May 2025 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
- 14 Nov 2024 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 15 May 2024 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 24 Apr 2024 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
- 24 Oct 2023 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 26 Apr 2023 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 25 Apr 2023 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
- 18 Oct 2022 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 18 Oct 2022 — LETTER OF SUSPENSION E-MAILED
- 18 Oct 2022 — SUSPENSION LETTER WRITTEN
- 23 Sept 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 08 Sept 2022 — USE AMENDMENT FILED